Intestinal IL-25 prevents high-fat diet-induced obesity by modulating the cholesterol transporter NPC1L1 expression in the intestinal epithelial cells

Abstract The intestine is essential for digestion and nutrient absorption, and its altered function contributes to metabolic dysregulation and obesity-induced intestinal inflammation. Intestinal immune responses have been associated with the regulation of metabolic dysfunction during obesity. Given...

Full description

Saved in:
Bibliographic Details
Main Authors: Siranart Jeerawattanawart, Pornpimon Angkasekwinai
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-95516-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850063802649804800
author Siranart Jeerawattanawart
Pornpimon Angkasekwinai
author_facet Siranart Jeerawattanawart
Pornpimon Angkasekwinai
author_sort Siranart Jeerawattanawart
collection DOAJ
description Abstract The intestine is essential for digestion and nutrient absorption, and its altered function contributes to metabolic dysregulation and obesity-induced intestinal inflammation. Intestinal immune responses have been associated with the regulation of metabolic dysfunction during obesity. Given that the epithelial cell-derived cytokine IL-25 has been demonstrated to regulate metabolic disorders, we sought to examine the role of intestinal IL-25 in modulating a high-fat diet (HFD)-induced obesity. We found that mice on a high-fat diet exhibited decreased IL-25 expression in the small intestine. Intestinal IL-25 mRNA levels displayed an inverse association with plasma triglycerides, total cholesterol, glucose levels, and the expression of the cholesterol transporter Npc1l1 in the intestine. In HFD-induced obesity, transgenic mice overexpressing IL-25 in the intestinal epithelial cells demonstrated diminished mRNA expression of intestinal genes related to glucose, cholesterol, and fat absorption, along with chylomicron production, while also systemically decreasing plasma glucose, total cholesterol, and triglyceride levels, fat accumulation, and weight gain. In vitro, IL-25 treatment of human intestinal Caco-2 cells directly decreased cholesterol uptake and downregulated the expression of NPC1L1 and its transcriptional regulator, SREBP2. These findings highlight IL-25 as a potential modulator in the intestine that regulates intestinal cholesterol absorption and systemic metabolism in obesity.
format Article
id doaj-art-9b8d0ff0c8fc4f37ad8621ccb34d76f0
institution DOAJ
issn 2045-2322
language English
publishDate 2025-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-9b8d0ff0c8fc4f37ad8621ccb34d76f02025-08-20T02:49:29ZengNature PortfolioScientific Reports2045-23222025-03-0115111510.1038/s41598-025-95516-7Intestinal IL-25 prevents high-fat diet-induced obesity by modulating the cholesterol transporter NPC1L1 expression in the intestinal epithelial cellsSiranart Jeerawattanawart0Pornpimon Angkasekwinai1Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat UniversityDepartment of Medical Technology, Faculty of Allied Health Sciences, Thammasat UniversityAbstract The intestine is essential for digestion and nutrient absorption, and its altered function contributes to metabolic dysregulation and obesity-induced intestinal inflammation. Intestinal immune responses have been associated with the regulation of metabolic dysfunction during obesity. Given that the epithelial cell-derived cytokine IL-25 has been demonstrated to regulate metabolic disorders, we sought to examine the role of intestinal IL-25 in modulating a high-fat diet (HFD)-induced obesity. We found that mice on a high-fat diet exhibited decreased IL-25 expression in the small intestine. Intestinal IL-25 mRNA levels displayed an inverse association with plasma triglycerides, total cholesterol, glucose levels, and the expression of the cholesterol transporter Npc1l1 in the intestine. In HFD-induced obesity, transgenic mice overexpressing IL-25 in the intestinal epithelial cells demonstrated diminished mRNA expression of intestinal genes related to glucose, cholesterol, and fat absorption, along with chylomicron production, while also systemically decreasing plasma glucose, total cholesterol, and triglyceride levels, fat accumulation, and weight gain. In vitro, IL-25 treatment of human intestinal Caco-2 cells directly decreased cholesterol uptake and downregulated the expression of NPC1L1 and its transcriptional regulator, SREBP2. These findings highlight IL-25 as a potential modulator in the intestine that regulates intestinal cholesterol absorption and systemic metabolism in obesity.https://doi.org/10.1038/s41598-025-95516-7IL-25IntestineNPC1L1Cholesterol absorptionObesity
spellingShingle Siranart Jeerawattanawart
Pornpimon Angkasekwinai
Intestinal IL-25 prevents high-fat diet-induced obesity by modulating the cholesterol transporter NPC1L1 expression in the intestinal epithelial cells
Scientific Reports
IL-25
Intestine
NPC1L1
Cholesterol absorption
Obesity
title Intestinal IL-25 prevents high-fat diet-induced obesity by modulating the cholesterol transporter NPC1L1 expression in the intestinal epithelial cells
title_full Intestinal IL-25 prevents high-fat diet-induced obesity by modulating the cholesterol transporter NPC1L1 expression in the intestinal epithelial cells
title_fullStr Intestinal IL-25 prevents high-fat diet-induced obesity by modulating the cholesterol transporter NPC1L1 expression in the intestinal epithelial cells
title_full_unstemmed Intestinal IL-25 prevents high-fat diet-induced obesity by modulating the cholesterol transporter NPC1L1 expression in the intestinal epithelial cells
title_short Intestinal IL-25 prevents high-fat diet-induced obesity by modulating the cholesterol transporter NPC1L1 expression in the intestinal epithelial cells
title_sort intestinal il 25 prevents high fat diet induced obesity by modulating the cholesterol transporter npc1l1 expression in the intestinal epithelial cells
topic IL-25
Intestine
NPC1L1
Cholesterol absorption
Obesity
url https://doi.org/10.1038/s41598-025-95516-7
work_keys_str_mv AT siranartjeerawattanawart intestinalil25preventshighfatdietinducedobesitybymodulatingthecholesteroltransporternpc1l1expressionintheintestinalepithelialcells
AT pornpimonangkasekwinai intestinalil25preventshighfatdietinducedobesitybymodulatingthecholesteroltransporternpc1l1expressionintheintestinalepithelialcells